Deciphera Pharmaceuticals, Inc.

JPMORGAN CHASE & CO

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/10/2024

Shares

60,453

Value ($000)

951

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/10/2024	951	0.0%	60,453	3/31/2024
2023 Q4	2/12/2024	1,406	0.0%	87,148	12/31/2023
2023 Q3	11/14/2023	1,052	0.0%	82,701	9/30/2023
2023 Q2	8/11/2023	1,131	0.0%	80,354	6/30/2023
2023 Q1	5/18/2023	1,058	0.0%	68,445	3/31/2023
2022 Q4	2/13/2023	1,213	0.0%	74,012	12/31/2022
2022 Q3	11/14/2022	1,468	0.0%	79,369	9/30/2022
2022 Q2	8/11/2022	556	0.0%	42,247	6/30/2022
2022 Q1	5/11/2022	3,369	0.0%	363,481	3/31/2022
2021 Q4	2/11/2022	1,211	0.0%	123,946	12/31/2021
2021 Q3	11/12/2021	907	0.0%	26,696	9/30/2021
2021 Q2	8/12/2021	998	0.0%	27,267	6/30/2021
2021 Q1	5/12/2021	1,055	0.0%	23,535	3/31/2021
2020 Q4	2/19/2021	983	0.0%	17,217	12/31/2020
2020 Q3	11/12/2020	691	0.0%	13,947	9/30/2020
2020 Q2	8/11/2020	754	0.0%	12,630	6/30/2020
2020 Q1	5/12/2020	279	0.0%	6,789	3/31/2020
2019 Q4	2/11/2020	5,427	0.0%	87,190	12/31/2019